Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3350641 | Human Immunology | 2010 | 6 Pages |
Abstract
Myeloid derived suppressor cells (MDSC) contribute to the negative regulation of immune response in cancer patients. This review summarizes results on important issues related to MDSC biology, including expansion and activation of MDSC, phenotype, and subsets as well pathways and different mechanisms by which these cells exert their suppressive effect. Recent observations suggesting that MDSC may have roles in transplant tolerance are presented. Although therapeutic targeting and destruction of MDCS is of primary interest in cancer patients, in transplantation it will instead be necessary to induce, expand, and activate these cells; thus current possibilities for in vitro generation of MDSC are also discussed.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Peter Boros, Jordi C. Ochando, Shu-Hsia Chen, Jonathan S. Bromberg,